news

interface news reporter | liu sunan

interface news editor | peng peng

"today's gains were very good. we had in-depth discussions with four or five companies." on september 8, 2024, song juan, a technical manager who came to the pujiang innovation forum "taozhan", told interface news.

the exhibition part of the 2024 pujiang innovation forum consists of the innomatch global technology transfer conference and the westart global venture capital conference, with a total exhibition area of ​​10,000 square meters.

among them, the global technology transfer conference has been held four times, releasing more than 16,000 technology demands and more than 20,000 national science and technology innovation talent job demands. more than 2,000 companies have released investment demands exceeding 75 billion yuan, and the amount of intended cooperation reached is nearly 10 billion yuan.

this year, the innomatch global technology transfer conference exhibited 15,000 national scientific and technological innovation talent needs and 4,000 unresolved technology needs online and offline; 20 large enterprises opened innovation platforms to gather demands, solutions and innovative products, and more than 10 national and regional pavilions brought together more than 100 overseas and domestic achievements.

westart global venture capital conference was launched in 2023, aiming to build an international and resource-based venture capital platform to "find" capital for projects and "find" projects for capital. the first 2023 westart facilitated 12 projects with a total investment intention of 270 million yuan on the same day. so far, the series of conference activities have cumulatively facilitated 32 investment cooperation intention projects with a total intended investment of approximately 1.17 billion yuan, and have attracted a total of 41 companies to settle in shanghai.

this year, the conference jointly organized a special roadshow with leading investment institutions and universities, such as cicc capital, zero2ipo group, and shanghai investment group, with more than 200 investment institutions on site to "look for projects."

the pujiang innovation forum has become an important platform for the transformation and application of scientific and technological elements.

last year, the global technology transfer conference technology managers' "tao" exhibition event was fully launched at the shanghai zhangjiang science hall. more than 100 "tao" exhibition technology managers discovered more than 100 needs, and the intended amount of cooperation contracts was nearly 500 million yuan.

technology managers are also known as "technology matchmakers". they serve scientific researchers and innovative entities such as enterprises, universities, medical institutions, and are committed to facilitating technology transactions. in recent years, with the rapid development of the transformation of scientific and technological achievements, the demand for technology managers has increased. this year, technology managers were selected as "leading talents" at the shanghai municipal level for the first time, highlighting the important value of this profession.

the 2024 global technology transfer conference focuses on the three core elements of "innovation needs, talent support, and capital power" and launches an exhibition event for thousands of technology managers.

song juan is from the technology transfer center and technology transfer co., ltd. of shanghai ocean university. this time, she brought marine biomedical projects such as tetrodotoxin extraction and zebrafish one-stop high-throughput screening platform. "as technology managers, we need to explore relevant technology needs and provide targeted r&d, joint r&d and other technology services for enterprises. on the other hand, we need to promote the projects on our platform and find partners for industrialization. we are both the supplier and demander of technology."

on september 8, song juan had in-depth exchanges with china resources pharmaceutical group and was quite interested in its technology transformation innovation center and international medical achievement transformation training camp.

there are problems in clinical medicine transformation, such as insufficient transformation service capabilities, difficulties in implementing industrialization and commercialization, deviations in clinical medical personnel's understanding of transformation, and insufficient integration of industry and medicine in scientific and technological innovation. in 2022, china resources pharmaceutical group unveiled the "shanghai international medical technology transformation and innovation center" (hereinafter referred to as the "medical innovation center"), creating a "one-stop" service platform to support clinical research and transformation of results.

at this global technology transfer conference, the medical innovation center and 100 technical managers in the medical professional field that have been trained made a joint appearance, released high-quality clinical results information from 26 medical and health institutions, sorted out 416 demand information from the industry, released r&d investment intentions from the market of nearly 20 million yuan, and sought technical consultants or r&d scientists in the fields of ivd and medical device consumables.

the international medical achievement transformation training camp was initiated by china resources pharmaceutical group and the national technology transfer eastern center and other institutions. its characteristics are "certification training + practical training + cross-border salon + community activities" in one. the training goal is to truly solve unmet clinical needs and industry needs, produce business plans for products or solutions that can be marketed, and discuss with the real market through various channels.

"for us technical managers, the training camp is an opportunity to learn practical skills and also to understand the entire industry through mutual communication. this is also very important and is a good communication platform," said song juan.

in the westart area, she found that china science and technology innovation center is very suitable for university projects.

focusing on key investment areas such as optoelectronic chips, artificial intelligence, aerospace, biotechnology, information technology, new materials, new energy, and intelligent manufacturing, zhongke chuangxing mainly invests in start-up and early-stage technology-based smes with growth potential and independent innovation capabilities. currently, zhongke chuangxing manages several funds with a total cumulative scale of over 10 billion yuan. as of the end of april 2024, it has invested in and incubated more than 470 hard technology companies.

"china's scientific and technological development has reached the stage where the most critical and core technologies must be solved; the current hard technology industry revolution includes artificial intelligence, photonic chips, life sciences, new energy, etc." mi lei, founding partner of china science and technology innovation, called on the venture capital community to "invest early, invest in small companies, invest for the long term, and invest in hard products" when delivering a keynote speech at the westart global venture capital conference.